Eurobio Scientific (FR0013240934, ALERS), the leading French group in the field of in vitro medical diagnostics and life sciences, joins the Enternext PEA PME 150 index of Euronext Paris from October 1st, 2019.

This index includes the 150 largest capitalizations, in terms of free float, among the companies listed on Euronext Paris or Euronext Growth Paris that are eligible for the PEA PME scheme and are among the 80% most liquid.

The PEA PME 150 index is particularly followed by institutional investors, in particular by the 20 specialized PEA PME funds.

Eurobio Scientific also joined the Euronext Tech Croissance index in 2019 and historically belongs to the Euronext Growth BPI Innovation and Euronext Growth Allshares indices.

To read the full article, please click here.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound